TY - JOUR
T1 - Whom to target for falls-prevention trials
T2 - Recommendations from the international MS falls prevention research network
AU - Cameron, Michelle
AU - Coote, Susan
AU - Sosnoff, Jacob J.
N1 - Publisher Copyright:
© 2014 Consortium of Multiple Sclerosis Centers.
PY - 2014
Y1 - 2014
N2 - Effective falls-prevention approaches for people with multiple sclerosis (MS) are needed. A significant challenge in studying falls-prevention programs for people with MS is deciding whom to include in trials. This article presents and discusses potential criteria for selecting participants for trials of falls-prevention interventions in MS. This narrative review reports on the inaugural meeting of the International MS Falls Prevention Research Network (IMSFPRN), which was held in March 2014 in Kingston, Ontario, Canada. Criteria considered were age, assistive device use, cognition, and fall history. The IMSFPRN reached consensus agreement to recommend that participants of all ages with varying levels of cognitive ability who are able to ambulate with or without assistance and who have a history of falling should be included in their future falls-prevention trials.
AB - Effective falls-prevention approaches for people with multiple sclerosis (MS) are needed. A significant challenge in studying falls-prevention programs for people with MS is deciding whom to include in trials. This article presents and discusses potential criteria for selecting participants for trials of falls-prevention interventions in MS. This narrative review reports on the inaugural meeting of the International MS Falls Prevention Research Network (IMSFPRN), which was held in March 2014 in Kingston, Ontario, Canada. Criteria considered were age, assistive device use, cognition, and fall history. The IMSFPRN reached consensus agreement to recommend that participants of all ages with varying levels of cognitive ability who are able to ambulate with or without assistance and who have a history of falling should be included in their future falls-prevention trials.
UR - http://www.scopus.com/inward/record.url?scp=84920431633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920431633&partnerID=8YFLogxK
U2 - 10.7224/1537-2073.2014-054
DO - 10.7224/1537-2073.2014-054
M3 - Article
C2 - 25694780
AN - SCOPUS:84920431633
SN - 1537-2073
VL - 16
SP - 203
EP - 207
JO - International Journal of MS Care
JF - International Journal of MS Care
IS - 4
ER -